Prominent phenotypic variability associated with mutations in ProgranulinBrendan Kelley, Ronald C. Petersen, Wael Haidar et al.|Neurobiology of Aging|2007Cited by 182
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trialAndrew McGarry, Karl Kieburtz, Jordan Dubow et al.|The Lancet Neurology|2023Cited by 128